Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,235.00
Bid: 2,242.00
Ask: 2,244.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.09%)
Open: 2,243.00
High: 2,269.00
Low: 2,218.00
Yest. Close: 2,228.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

BUZZ-Tullow: Ghana worries add to FTSE relegation fears

** Tullow Oil easily top FTSE 100 faller, down 7.3 pct & poised for biggest one-day drop since late Nov ** Worries that an ongoing maritime dispute between Ghana and Cote d'Ivoire could result in suspension of ops see shares accelerate losses after weak open ** Tullow got 85 pct of it

2 Mar 15 11:55

Sector movers: GSK leads defensive pharma stocks higher

A massive cash return by Glaxosmithkline gave the wider sector a lift on Wednesday, with defensive healthcare and pharmaceutical stocks also benefiting from a reduction in risk appetite as UK markets pulled back from a five-month high. Sales, profits and earnings slumped during the fourth quarter of

4 Feb 15 14:35

UK BROKER RATINGS: Morgan Stanley Upgrades Barclays To Overweight

3 Feb 15 09:38

UK BROKER RATINGS: Bernstein Raises ITV And Sky To Outperform

13 Jan 15 09:56

MARKET COMMENT: London Closes Mixed As Oil Prices Resume Fall

12 Jan 15 17:11

BUZZ-Hikma Pharmaceuticals: life-high after appeal against co's drug fails

** Drugmaker's shares up 4.4 pct to life-high after Hikma says Takeda Pharmaceutical unsuccessful in appealing U.S. court decision to deny preliminary injunction of the Jordanian company's drug for gout flares. ** Hikma is the top gainer on the FTSE-350 Pharmaceuticals & Biotechnology index

12 Jan 15 13:21

UK WINNERS & LOSERS: Afren Plummets After Barda Rash Downgrade

12 Jan 15 11:35

UK MORNING BRIEFING: Shire Sets Out Ambitions With USD5.2 Billion Buy

12 Jan 15 08:14

Hikma Pharmaceuticals hiked by court colchicine ruling

A US court has given Hikma Pharmaceuticals permission to distribute its colchicine gout treatment, turning down rival Takeda Pharmaceuticals in its appeal for an injunction against the distribution of the drugs. The injunction, which was granted to Takeda on 9 October 2014, has been vacated followin

12 Jan 15 08:08

Hikma To Launch Cochicine Capsules After Takeda's Appeal Fails

12 Jan 15 07:40

FTSE 250 movers: Energy sector struggles as oil price continues to slide

Oil producers such as Afren and Premier Oil, and energy services firms Wood Group, Hunting and Petrofac, were all falling sharply on Monday as the price of oil continued to sink. Brent crude dropped below $55 a barrel (bbl) for the first time since May 2009. Afren was also continuing to decline afte

5 Jan 15 14:04

London midday: Resource stocks drag FTSE 100 into the red

UK stocks were trading firmly in the red by Monday lunchtime despite a positive start, with shares in the oil and mining sectors providing a drag. London's FTSE 100 was down 0.9% at 6,489 by midday, dropping sharply after reaching a high of 6,576.74 early on. This week will be the first full tradin

5 Jan 15 11:36

Hikma soars after bullish recommendation from brokers

Hikma Pharmaceuticals shares edged closer to an all-time high on Monday, in the wake of bullish recommendation from two brokers. The stock, which rose 66.8% in 2014, was among Europe's best performing small-cap after JP Morgan lifted its price target on Hikma shares by 18.4% and maintained an 'overw

5 Jan 15 10:14

BUZZ-Hikma: back near record highs, top-ranked brokers come out in favour

** Hikma Pharmaceuticals, up 3.7 pct and close to testing all-time high again after two 5-star rated brokers issue bullish recommendations on stock. ** Stock is Europe's best performing small-cap, extends 2014's stellar run that saw stock up 66.8 pct. ** JPMorgan lifts its PT on stock

5 Jan 15 08:23

Sector movers: Defensive pharma stocks fall as Santa Rally continues

Pharmaceutical and healthcare stocks were leading the fallers on Tuesday as investors dumped defensive assets amid a continued pre-Christmas rally. UK stocks have risen for six straight days as markets rebounded strongly following a recent sell-off. While more cyclical sectors such as construction

23 Dec 14 16:18

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.